Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMBRACA: Talazoparib vs Chemotherapy in gBRCA+ Advanced Breast Cancer
NCT01945775Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2013
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of talazoparib in breast cancer, sponsored by Pfizer. Started Oct 2013; status: completed.
02
Drugs
talazoparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01945775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01945775.